PATENT CLAIM ANALYSIS

Application Number: 16170344
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "168100"]

Abstract:
Species of human-derived bacteria belonging to the Clostridia class have been shown to induce accumulation of regulatory T cells (Treg cells) in the colon and suppress immune functions. Pharmaceutical compositions containing these bacteria can be used to prevent and treat immune-mediated diseases such as autoimmune diseases.

Claim (Index 2):
The composition of  claim 1 , wherein the purified bacterial mixture comprises at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, at least 11, at least 12, at least 13, at least 14, at least 15, at least 16 or at least 17 bacterial strains.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 97.0
- Lexical Diversity: 1.21951
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14362097', '16160004', '15487553', '15019068', '15964285']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.91991113600244
- 35 USC 102 Novelty (BERT): 0.7392275608716042
- Combined Prediction Score: 0.9018427784893566
- Mean Citation Score: 1147.21884
- Max Citation Score: 1272.8943
- Similarity Product: 864.2114942569613

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test